Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
Sumeet Pal Singh, Vinita Gouri, Mukesh Samant
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 10

Showing 10 citing articles:

Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy
Shaida Ouladan, Elias Orouji
Journal of Clinical Oncology (2025)
Closed Access
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 5
Curcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy
Aranka Brockmueller, Vicenç Ruiz de Porras, Mehdi Shakibaei
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3525-3551
Open Access | Times Cited: 4
Different origin-derived exosomes and their clinical advantages in cancer therapy
Xiaoyan Jin, Jing Zhang, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
New advances in cancer therapy targeting TGF-β signaling pathways
Minyue Shou, Hanyu Zhou, Ling Ma
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100755-100755
Open Access | Times Cited: 8
Recent advances and molecular mechanisms of TGF-β signaling in colorectal cancer, with focus on bioactive compounds targeting
Saad Bakrim, Naoufal El Hachlafi, Asaad Khalid, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116886-116886
Open Access | Times Cited: 2
Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer
Hui Shan, Guangyu Tian, Yeqing Zhang, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome
Toshihide Maeda, Yohei Shirakami, Daisuke Taguchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11640-11640
Open Access
Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers
Qinlan Xu, Dong Shao
Frontiers in Immunology (2024) Vol. 15
Open Access
Potentiating CAR-T-cell function in the immunosuppressive tumor microenvironment by inverting the TGF-β signal
Zheng Shen, Xuan Che, Kai Zhang, et al.
Molecular Therapy (2024)
Closed Access
Page 1

Scroll to top